Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus

Background: The origin of autoimmune disease type 1 diabetes is still unknown. Aim: This study assessed the activation of CD4+ and CD8+ T-lymphocytes by human insulin and human glutamate decarboxylase (GAD) in patients with type 1 or type 2 diabetes mellitus (DM) and healthy volunteers. Materials...

Full description

Bibliographic Details
Main Author: Borros Arneth
Format: Article
Language:English
Published: Bioscientifica 2017-11-01
Series:Endocrine Connections
Subjects:
Online Access:http://www.endocrineconnections.com/content/6/8/758.full
_version_ 1828171175993278464
author Borros Arneth
author_facet Borros Arneth
author_sort Borros Arneth
collection DOAJ
description Background: The origin of autoimmune disease type 1 diabetes is still unknown. Aim: This study assessed the activation of CD4+ and CD8+ T-lymphocytes by human insulin and human glutamate decarboxylase (GAD) in patients with type 1 or type 2 diabetes mellitus (DM) and healthy volunteers. Materials and methods: The expression of CD69, a marker of T-lymphocyte activity, was determined in whole blood samples by flow cytometry after 12 h of incubation with or without insulin or GAD. The analysis included samples from 12 type 1 DM patients, 14 type 2 DM patients and 12 healthy volunteers. Results: Significant increases in the number of activated CD4+ and CD8+ T-lymphocytes following pre-incubation of whole blood samples with human insulin or GAD were observed in samples from patients with type 1 DM, whereas no activation of these cells was detected in samples from either type 2 DM patients or healthy subjects. Discussion: These results indicated that latent pre-activation of CD4+ and CD8+ T-lymphocytes in response to insulin or GAD epitopes occurred in type 1 DM patients. Conclusion: These findings suggest that pre-immunization against insulin and/or GAD might be associated with the development of type 1 DM. Alternatively, these results might reflect a non-specific, bystander autoimmune response.
first_indexed 2024-04-12T03:23:27Z
format Article
id doaj.art-ee8b2738bb544d25831fca7ffa5e67e0
institution Directory Open Access Journal
issn 2049-3614
2049-3614
language English
last_indexed 2024-04-12T03:23:27Z
publishDate 2017-11-01
publisher Bioscientifica
record_format Article
series Endocrine Connections
spelling doaj.art-ee8b2738bb544d25831fca7ffa5e67e02022-12-22T03:49:48ZengBioscientificaEndocrine Connections2049-36142049-36142017-11-016875876510.1530/EC-17-0230Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitusBorros Arneth0Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, University Hospital of the Universities of Giessen and Marburg, UKGM, Justus Liebig University, Giessen, Giessen, GermanyBackground: The origin of autoimmune disease type 1 diabetes is still unknown. Aim: This study assessed the activation of CD4+ and CD8+ T-lymphocytes by human insulin and human glutamate decarboxylase (GAD) in patients with type 1 or type 2 diabetes mellitus (DM) and healthy volunteers. Materials and methods: The expression of CD69, a marker of T-lymphocyte activity, was determined in whole blood samples by flow cytometry after 12 h of incubation with or without insulin or GAD. The analysis included samples from 12 type 1 DM patients, 14 type 2 DM patients and 12 healthy volunteers. Results: Significant increases in the number of activated CD4+ and CD8+ T-lymphocytes following pre-incubation of whole blood samples with human insulin or GAD were observed in samples from patients with type 1 DM, whereas no activation of these cells was detected in samples from either type 2 DM patients or healthy subjects. Discussion: These results indicated that latent pre-activation of CD4+ and CD8+ T-lymphocytes in response to insulin or GAD epitopes occurred in type 1 DM patients. Conclusion: These findings suggest that pre-immunization against insulin and/or GAD might be associated with the development of type 1 DM. Alternatively, these results might reflect a non-specific, bystander autoimmune response.http://www.endocrineconnections.com/content/6/8/758.fulltype 1 diabetes mellitustype 2 diabetes mellitusCD4+ T-lymphocytesCD8+ T-lymphocytesautoimmunityautoantibodiesinsulinGAD
spellingShingle Borros Arneth
Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
Endocrine Connections
type 1 diabetes mellitus
type 2 diabetes mellitus
CD4+ T-lymphocytes
CD8+ T-lymphocytes
autoimmunity
autoantibodies
insulin
GAD
title Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
title_full Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
title_fullStr Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
title_full_unstemmed Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
title_short Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
title_sort activation of cd4 and cd8 t lymphocytes by insulin and gad in patients with type 1 or 2 diabetes mellitus
topic type 1 diabetes mellitus
type 2 diabetes mellitus
CD4+ T-lymphocytes
CD8+ T-lymphocytes
autoimmunity
autoantibodies
insulin
GAD
url http://www.endocrineconnections.com/content/6/8/758.full
work_keys_str_mv AT borrosarneth activationofcd4andcd8tlymphocytesbyinsulinandgadinpatientswithtype1or2diabetesmellitus